Bainbridge Health Partners with Tabula Rasa HealthCare’s subsidiary DoseMe To Expand Medication Management Capabilities to Health Systems(s)

See more here


VenatoRx Pharmaceuticals Expands Development Team as It Advances Its Antibacterial and Antiviral Portfolio
Key Hires in Quality Assurance, Medical Sciences and Regulatory Affairs 

See more here


Group K Diagnostics and Health Network Laboratories Announce the Commencement of a Clinical Trial

See more here


Renovacor Closes $11 Million Series A Financing to Advance First Gene Therapy for a Rare Cardiovascular Disease
– Funding supports preclinical development through IND submission for its BAG3 gene therapy, the first gene replacement product for genetic forms of dilated cardiomyopathy
– Company announces leadership team and board of directors with leading scientists, physicians and experienced venture investors in cardiovascular and gene therapy fields

See more here


Relmada Therapeutics Announces Completion of Dosing with REL-1017 in Phase 2 Study of Individuals with Treatment Resistant Depression
REL-1017 is a novel NMDA receptor antagonist in development as a rapidly acting oral agent for the treatment of depression 

See more here


HHS, DoD, VenatoRx Pharmaceuticals to Co-Develop Novel Antibiotic to Treat Drug-Resistant Infections

See more here


South Shore Health Selects Bainbridge Health to Enhance Medication Safety and Stewardship
Bainbridge Health is partnering with South Shore Health, a leading provider of emergency, acute and outpatient care, to enhance its efforts to improve safety and reduce medication waste. 

See more here


Immunome Appoints Purnanand Sarma, PhD, as President and Chief Executive Officer
Industry Veteran to Take the Helm of Next-Generation Oncology Company Focused on Harnessing Human Immune Response  

See more here


QR Pharma Adopts new Corporate Name: Annovis Bio
Change reflects enhanced focus on neurodegenerative diseases 

See more here